The Rabbit Polyclonal anti-TCL1A antibody has been validated for WB and FACS. It is suitable to detect TCL1A in samples from Human. There are 3+ publications available.
This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This TCL1A antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 32-66 amino acids from the Central region of human TCL1A.
TCL1A
Reactivity: Human
WB
Host: Rabbit
Polyclonal
unconjugated
Application Notes
WB: 1:1000. FC: 1:25
Restrictions
For Research Use only
Format
Liquid
Buffer
Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Expiry Date
6 months
Laine, Künstle, Obata, Sha, Noguchi: "The protooncogene TCL1 is an Akt kinase coactivator." in: Molecular cell, Vol. 6, Issue 2, pp. 395-407, (2000) (PubMed).
Virgilio, Narducci, Isobe, Billips, Cooper, Croce, Russo: "Identification of the TCL1 gene involved in T-cell malignancies." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 91, Issue 26, pp. 12530-4, (1995) (PubMed).
Fu, Virgilio, Narducci, Facchiano, Russo, Croce: "Characterization and localization of the TCL-1 oncogene product." in: Cancer research, Vol. 54, Issue 24, pp. 6297-301, (1995) (PubMed).
Target
TCL1A
(T-Cell Leukemia/lymphoma 1A (TCL1A))
Alternative Name
TCL1A
Background
Enhances the phosphorylation and activation of AKT1, AKT2 and AKT3. Promotes nuclear translocation of AKT1. Enhances cell proliferation, stabilizes mitochondrial membrane potential and promotes cell survival.